Skip to main content
OpenTrials
Completed

NCT Number: NCT02437474

Impact of Elimination or Reduction of Dietary Animal Proteins on Cancer Progression and Survival - A Pilot Study

The purposes of this study are

* to test the hypothesis that elimination or reduction of dietary animal proteins leads to an improved prognosis in tumor patients * to estimate the effect size and thus to enable sample size calculations for further studies * to test the feasibility and tolerance of different diets, especially a vegan diet, in cancer patients and to proof that a vegan diet does not lead to a deterioration of health, tumor progression or to malnutrition * to test the online platform as a study platform * to test validity of self reported and online generated data

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Verein Essen und Krebs

Vienna, 1060, Austria

About this study

Participating cancer patients select one of 3 defined diets (omnivor/lacto-ovo-vegetarian/vegan) at baseline and will continue their prescribed oncological therapy at their attending physician/clinic.

Participants provide data (cancer history, tumor behavior, food frequency questionnaires, questionnaires referring to quality-of-life) at baseline and at 3 and 6 months with optional data entry points at 12 and 124 months and a follow up questionnaire at 12 and 24 months. Data is entered online via the study platforms www.essenundkrebs.net and www.foodandcancer.net in German and English language (no additional clinical visits are required).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of cancer
  • Inclusion in a tumor treatment or follow-up program
  • Age >18 years

Exclusion criteria

  • Psychiatric treatment during the last 3 months
  • Pregnancy
  • Breast feeding
  • BMI < 18,5 kg/m2
  • Major difficulties with food intake (swallowing, lack of appetite) limiting food intake
  • Participation in other studies requiring the attendance to a particular diet

Treatment and study plan

Omnivorous diet

Behavioral

Adopting or continuing the selected diet for 6 months (omnivorous)

Lacto-ovo-vegetarian diet

Behavioral

Adopting or continuing the selected diet for 6 months (lacto-ovo-vegetarian)

Vegan diet

Behavioral

Adopting or continuing the selected diet for 6 months (vegan)

Primary outcomes

  1. Number / percentage of remissions

    Time frame: 6 months

    Percentages of remissions as defined be complete absence of a tumor - in an ITT (intention to treat) analysis

Secondary outcomes

  1. Tumor diagnosis and tumor behaviour (complete remission / partial remission / no change / progression)

    Time frame: 3 and 6 months (optional: 12 and 24 months)

    In the fist questionnaire, tumor history (diagnosis, classification, stage, previous therapy) is entered. At months 0, 3, 6, 12 and 24 tumor stage at present time is asked again. Comparing the staging between time points, tumor behaviour is categorized into four groups: complete remission / partial remission / no change / tumor progression. This will be determined for each participant by two investigator independently.

  2. Relapse-free interval

    Time frame: 0, 3, 6, 12 and 24 months

    A relapse is defined by a recurrence of a tumor after a tumor free interval.

  3. Therapies, therapy tolerability and side-effects (vomiting, nausea, hair loss, weakness, diarrhea, polyneuropathy,...)

    Time frame: 0, 3 and 6 months (optional: 12 and 24 months)

    The study questionnaire contains questions referring frequently occuring symptoms in cancer patients and wether they are related to a certain therapy or to other factors. The option "others" is included in case the present symptoms are not covered by the listed symptoms.

  4. Comorbidities

    Time frame: 0, 3 and 6 months (optional: 12 and 24 months)

    The study questionnaire contains questions referring frequently occuring diseases other than cancer and wether they are present now or were present in the past. The option "others" is included in case the present disease is not covered by the listed diseases.

  5. Medication

    Time frame: 0, 3 and 6 months (optional: 12 and 24 months)

    The study questionnaire contains questions referring medications and supplements and the dosage.

  6. Quality of life

    Time frame: 0, 3 and 6 months (optional: 12 and 24 months)

    The study questionnaire contains questions referring quality of live covering the Karnofsky Index, but additional dimensions, too (psychosocial wellbeing).

  7. Acceptance and feasibility of the selected diet

    Time frame: 3 and 6 months (optional: 12 and 24 months)

    The study questionnaire contains questions referring ease and difficulties with the selected diet.

  8. Dietary pattern

    Time frame: 0, 3, 6, 12 and 24 months

    The study questionnaire contains questions referring previous dietary patterns and the dietary pattern which will be followed for the time of study participation (6 months) as well as the reason for choosing the respective diet. There is a categorical question asking for dietary patterns as well a comprehensive food frequency questionnaire especially adopted for discrimination of plant an animal derived foods.

    In addition to the main study questionnaires, participants are asked to report any unplanned change in their diet during study participation.

  9. Frequency, extent and duration of nutritional changes

    Time frame: 3 and 6 months (optional: 12 and 24 months)

    The results referring to nutrition and dietary patterns are evaluated in terms of change and duration of change in dietary patterns (in months).

  10. Weight and nutritional status

    Time frame: 0, 3, 6, 12 and 24 months

    Weight is entered in kg and size in cm. BMI is calculated. Nutritional status is derived from weight changes, laboratory test results (albumin) and questions referring to eating problems contained in the study questionnaire.

  11. Experience with / performance of study platform

    Time frame: 0, 3 and 6 months

    One question of the questionnaire asks for experience and usability of the comprehensive questionnaire in terms of content, understanding, effort und technical experience.

  12. Validity checks for self reported data

    Time frame: 0, 3 and 6 months

    Several questions are repeated in the questionnaire in a slightly different way to check for consistency. Dietary patterns are checked via food frequency questionnaires and control questions in the laboratory test section.

  13. Survival rates for end stages

    Time frame: 6 months, 12 and 24 months

    Survival rates are calculated from the participants still alive and dead. In case of a pending questionnaire a contact person is asked or a cancer registry checked (depending on the citizenship of the participant).

Sponsors and collaborators

Lead sponsor

Rosa Aspalter

Other

Collaborators

  • University Hospital Regensburg

Registry information

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
May 7, 2015
Registry last updated
Nov 7, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.